Q3 2025 Earnings Call Transcript November 12, 2025 Humacyte, Inc. beats earnings expectations. Reported EPS is $-0.14, ...

Total revenues of $753,000 for third quarter, and $1,571,000 for first nine months of 2025, from sales and collaborative research agreement - - Major advances in pipeline as Humacyte moves closer to ...

Humacyte, Inc. ( HUMA) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Good morning, ladies and gentlemen, and welcome to the Humacyte's Third Quarter Results Conference Call. [Operator ...

Humacyte's Q3 2025 earnings show strong Symvess sales growth, expanded hospital/military access, and financial stability.

During your initial knee or hip replacement surgery, the prosthetic (artificial) components were either cemented (attached with bone cement) or hammered into the bone so they could eventually attach ...